USPTO Assignments on the Web

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total properties: 237
Page 1 of 3
Pages: 1 2 3

PROGESTATIONALLY ACTIVE 19,11-BRIDGED 4-ESTRENES

CONJUGATES MADE OF METAL COMPLEXES AND OLIGONUCLEOTIDES, AGENTS CONTAINING THE CONJUGATES, THEIR USE IN RADIODIAGNOSIS AS WELL AS PROCESS FOR THEIR PRODUCTION

COMBINED PHARMACEUTICAL PREPARATION CONTAINING LHRH-ANALOGOUS SUBSTANCES AND ANTI ESTROGENS FOR TREATING GYNAECOLOGICAL DISORDERS

USE OF METAL CHELATES AS RADIOSENSITIZERS

USE OF INTRAVENOUS CONTRAST AGENTS AND DEVICES FOR PROJECTION MAMMOGRAPHY

PROCESS FOR THE PRODUCTION OF FLUDARABINE-PHOSPHATE LITHIUM, SODIUM, POTASSIUM, CALCIUM AND MAGNESIUM SALTS AN PURIFICATION PROCESS FOR THE PRODUCTION OF FLUDARABINE-PHOSPHATE AND FLUDARABINE-PHOSPHATE WITH A PURITY OF AT LEAST 99.5%

EPOTHILONE DERIVATIVES, METHOD FOR PRODUCING SAME AND THEIR PHARMACEUTICAL USE

NEAR INFRARED FLUORESCENT CONTRAST AGENT AND FLUORESCENCE IMAGING

Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Stabilization of radionuclide-containing compositions

interferon for the treatment of multiple sclerosis

Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use

Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders

Receptor of the EDb-fibronectin domains

NEAR INFRARED FLUORESCENT CONTRAST AGENT AND FLUORESCENCE IMAGING

Use and compositions of antiprogestins for treatment of prostate diseases

Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy

Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients

8BETA-SUBSTITUTED-11-BETA-PENTYL-AND 11-BETA-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES

8 BETA-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS

Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis

17BETA- ESTRADIOL/LEVONORGESTREL TRANSDERMAL PATCH FOR HORMONE REPLACEMENT THERAPY

SYNTHESIS OF OXYGEN-SUBSTITUTED BENZOCYCLOHEPTENES AS VALUABLE INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF TISSUE-SELECTIVE ESTROGENS

Solid pharmaceutical agent formulation for a piperazine urea derivative

N-METHYL-HOMOCYSTEINES AND THEIR USE AS WELL AS PROCESS FOR THEIR PRODUCTION

Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the aid of said device

Near infrared fluorescent contrast agent and fluorescence imaging

Calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.O)methyl]-1-[(4,4-diphenylcyclohexy)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.Kappa.N9,.Kappa 011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents

Combination preparation with a erbeta selective estrogen and serm or antiestorgen

PROCESS FOR THE OVEREXPRESSION OF DEHYDROGENASES

Nonsteroidal gestagens

Microglia inhibitors for interrupting interleukin 12 and IFN-gamma-mediated immune reactions

Use of Epothilones in the treatment of brain diseases associated with proliferative processes

17Alpha fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds

NON-STEROIDAL PROGESTING

CDK-INHIBITORY 2-HETEROARYL-PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS

Inhibition of the growth factor dependency of tumor cells

Use of antiprogestins for the induction of apoptosis in a cell

USE OF ANTIPROGESTINS FOR PROPHYLAXIS AND TREATMENT OF HORMONE-DEPENDENT DISEASES

Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof

Treatment of hypertension in women receiving hormone replacement therapy

Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases

Use of orally available prostacyclin derivatives for the production of a pharmaceutical agent for treating diseases that are associated with bone marrow edemas

METHOD FOR TESTING HORMONAL EFFECTS OF SUBSTANCES

9-ALPHA-SUBSTITUTED ESTRATRIENES AS SELECTIVELY ACTIVE ESTROGENS

Metal complex-containing pharmaceutical agents

ANDROGENIC 7-SUBSTITUTED 11-HALOGEN STEROIDS

N-OXIDE ANTHRANYLAMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS

CYANOANTHRANILAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS

Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3

3,5-Diamino-1,2,4-triazoles as kinase inhibitors

Selective targeting of tumor vasculature using antibody molecules

THIAZOLIDINONES AND THE USE THEROF AS POLO-LIKE KINASE INHIBITORS

Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said composition

Epididymis-specific gene as potential contraceptive target

PROTECTED 5,7-DIHYDROXY-4,4-DIMETHYL-3-OXOHEPTANOIC ACID ESTERS AND 5,7-DIHYDROXY-2-ALKYL-4,4-DIMETHYL-3-OXOHEPTANOCI ACID ESTERS FOR THE SYNTHESIZING OF EPOTHILONE AND EPOTHILONE DERIVATIVES AND PROCESS FOR THE PRODUCTION OF THESE ESTERS

Method for producing c1-c15 fragments of epothilones and the derivatives thereof

THIOMORPHOLINO STEROID COMPOUNDS, THE USE THEREOF FOR THE PREPARATION OF MEIOSIS-REGULATING MEDICAMENTS AND METHOD FOR THE PREPARATION THEREOF

Extended Use Combination Comprising Estrogens And Progestins

Method for fertility control

USE OF PERFLUOROALKYL-CONTAINING METAL COMPLEXES AS CONTRAST MEDIA IN MR-IMAGING FOR VISUALIZATION OF INTRAVASCULAR THROMBI

FOLDING BOX WITH FOLD-DOWN ATTACHMENT FLAP

MICROBIOLOGICAL PROCESS FOR THE PRODUCTION OF 7-SUBSTITUTED 11-HYDROXY STEROIDS, 7, 17-SUBSTITUTED 11-HALOGEN STEROIDS AND USES THEREOF

MACROCYCLIC PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS

Process for the production of ergosterol and its intermediate products using recombinant yeasts

Epididymis-specific receptor protein and its use

Receptor of the EDb-fibronectin domains

Pharmaceutical preparations, use of these preparations and process for increasing the biovailability of pharmaceutical substances to be administered perorally

CHK-, PDK- AND AKT-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS

NEW PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF DISEASES RESULTING FROM PERSISTENT ANGIOGENSIS

Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Enhanced scintigraphic imaging agents for imaging of infection and inflammation

Hydrophilic, thiol-reactive cyanine dyes and conjugates thereof with biomolecules for fluorescence diagnosis

ENANTIOMER-PURE (4S,8S)- AND (4R,8R)-4-P-NITROBENZYL-8-METHYL-3,6,9-TRIAZA-3N,6N,9N-TRICARBOXYMETHYL-1,11-UNDECANEDIOIC ACID AND DERIVATIVES THEREOF, PROCESS FOR THEIR PRODUCTION AND USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS

Combinations and compositions which interfere with VEGF/ VEGF and angiopoietin/ Tie receptor function and their use (II)

Substituted N-(1,4,5,6,-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents

8BETA-VINYL-11BETA-(OMEGA-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES

PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE INGREDIENTS

PROCESS FOR THE PRODUCTION OF HIGH-PURITY RAC-1-{4-[2-HYDROXY-3-(5-QUINOLYLOXY)PROPYL]-PIPERAZIN-1-YL}-2,2-DIPHENYLETHAN-1-ONE FUMARATE AND HIGH-PURITY RAC-1-{4-[2-HYDROXY-3-(5-QUINOLYLOXY)PROPYL]PIPERAZIN-1-YL}-2,2-DIPHENYLETHAN-1-ONE FUMARATE

CDK-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS

Use of intravenous contrast media for projection mammography

Composition comprising progesterone-receptor antagonists and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases

USE OF PERFLUOROALKYL-CONTAINING METAL COMPLEXES AS CONTRAST MEDIA IN MR-IMAGING FOR VISUALIZATION OF PLAQUE, TUMORS AND NECROSES

Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient

Quinolyl amide derivatives as CCR-5 antagonists

VEGFR-2 AND VEGFR-3 INHIBITORY ANTHRANILAMIDE PYRIDINES

Hormone replacement therapy and depression

Device and process for direct quantitative in vitro determination of a substance that is contained in a sample

Emitter-binding peptides that produce a change in the spectral emission properties of the emitter

CONTRACEPTION METHOD USING COMPETITIVE PROGESTERONE ANTAGONISTS AND NOVEL COMPOUNDS USEFUL THEREIN

Use of ERbeta-selective ligands for regulating fertility and compounds useful therefor

DELTA15-D-HOMOSTEROIDS WITH ANDROGENIC ACTION

Chemokine inhibiting piperazine derivatives and their use to treat myocarditis

X-RAY ARRANGEMENT AND X-RAY CONTRAST PROCESS FOR IMAGING AN OBJECT UNDER EXAMINATION THAT CONTAINS AT LEAST ONE RADIOPAQUE ELEMENT AS WELL AS USE OF THE X-RAY ARRANGEMENT

6-ALKENYL-, 6-ALKINYL- AND 6-EPOXY-EPOTHILONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE IN PHARMACEUTICAL PREPARATIONS

SULFOXIMINE-SUBSTITUTED PYRIMIDINES AS CDK-AND/OR VEGF INHIBITORS, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS

Thiazolidinones, their production and use as pharmaceutical agents

Combination contraceptive, kits that contain the latter, and a method that uses the latter

Benzylether amine compounds useful as CCR-5 antagonists

Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol

Correspondence name and address

MILLEN, WHITE, ZELANO & BRANIGAN PC

2200 CLARENDON BLVD. SUITE 1400

Search Results as of: 05/08/2024 05:27 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help